We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

60 hedge funds and large institutions have $9.86M invested in Acorda Therapeutics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% less funds holding

Funds holding: 79 → 60 (-19)

44% less capital invested

Capital invested by funds: $17.6M → $9.86M (-$7.75M)

64% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 28

83% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 23

87% less call options, than puts

Call options by funds: $103K | Put options by funds: $793K

Holders
60
Holders Change
-19
Holders Change %
-24.05%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
28
Closed
23
Calls
$103K
Puts
$793K
Net Calls
-$690K
Net Calls Change
+$1.61M

Top Buyers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$894K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$468K
3
GCP
GSA Capital Partners
United Kingdom
+$388K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$80.3K
5
Citadel Advisors
Citadel Advisors
Florida
+$72.9K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$925K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$720K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$706K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$464K
5
Millennium Management
Millennium Management
New York
-$389K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$26K – – –
State Street
27
State Street
Massachusetts
$19K – – –
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$17K -$15.4K -204 -43%
PPA
29
Parametric Portfolio Associates
Washington
$16K – – –
LPL Financial
30
LPL Financial
California
$15K +$12.6K +167 +201%
SM
31
Salzhauer Michael
$14K – – –
SG Americas Securities
32
SG Americas Securities
New York
$13K -$1.81K -24 -11%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$13K – – –
SBIA
34
Sheaff Brock Investment Advisors
Indiana
$13K – – –
Ohio Public Employees Retirement System (OPERS)
35
Ohio Public Employees Retirement System (OPERS)
Ohio
$13K +$15.5K +206 New
QI
36
QS Investors
New York
$11K -$49K -650 -79%
Charles Schwab
37
Charles Schwab
California
$9K -$111K -1,473 -92%
LP
38
LMR Partners
United Kingdom
$9K -$1.81K -24 -15%
RA
39
Royce & Associates
New York
$9K – – –
Morgan Stanley
40
Morgan Stanley
New York
$8K -$12.2K -162 -56%
WS
41
Wedbush Securities
California
$8K -$6.18K -82 -39%
HB
42
Homrich & Berg
Georgia
$8K +$9.43K +125 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$6K -$10.3K -137 -58%
BMC
44
Benin Management Corp
Connecticut
$6K – – –
CL
45
CSS LLC
Illinois
$6K – – –
GWM
46
Geneos Wealth Management
Colorado
$6K – – –
GF
47
Gabelli Funds
New York
$5K -$6.26K -83 -49%
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$4.01K -$72K -955 -94%
SDIC
49
South Dakota Investment Council
South Dakota
$3K – – –
NC
50
NewSquare Capital
Pennsylvania
$2K – – –
1
2
3 4

ACOR Hedge Fund Activity: Q3 2020 in Review

60 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2020, worth a combined $9.86M — down 44% from $17.6M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ACOR and 4 opened new positions — a net loss of 19 holders — while 28 trimmed existing stakes and 10 added.

The largest buyer was Parallax Volatility Advisers, adding an estimated $894K. The largest seller was Dimensional Fund Advisors, cutting an estimated $925K.

  • 60 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2020, down from 79 in Q2 2020.
  • Funds reported $9.86M of Acorda Therapeutics stock for Q3 2020, down 44% quarter-over-quarter.
  • 4 funds opened new Acorda Therapeutics positions in Q3 2020 and 23 closed out, a net change of -19 holders.
  • The largest Acorda Therapeutics buyer in Q3 2020 was Parallax Volatility Advisers, an estimated $894K added.
  • The largest Acorda Therapeutics seller in Q3 2020 was Dimensional Fund Advisors, an estimated $925K sold.

Based on aggregated 13F filings for Q3 2020.